Our C4 deposition assay is dependent primarily on functional MBL plasma levels in both healthy controls and patients with SLE, and C4 is not a limiting factor until very low concentrations of 0.01 g/l in healthy controls. Here, C4A is linked to systemic lupus erythematosus.